Evaluating the safety and efficacy of medical management in extracranial pseudoaneurysms: a comparative study.

IF 3.5 2区 医学 Q1 CLINICAL NEUROLOGY
Jean Filo, Felipe Ramirez-Velandia, Donna Lawlor, Michael Young, Samuel D Pettersson, Thomas B Fodor, Alejandro Enriquez-Marulanda, Sandeep Muram, John McDonald, Max Shutran, Justin H Granstein, Philipp Taussky, Robert D Ecker, Christopher S Ogilvy
{"title":"Evaluating the safety and efficacy of medical management in extracranial pseudoaneurysms: a comparative study.","authors":"Jean Filo, Felipe Ramirez-Velandia, Donna Lawlor, Michael Young, Samuel D Pettersson, Thomas B Fodor, Alejandro Enriquez-Marulanda, Sandeep Muram, John McDonald, Max Shutran, Justin H Granstein, Philipp Taussky, Robert D Ecker, Christopher S Ogilvy","doi":"10.3171/2024.6.JNS24732","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>As endovascular interventions become safer and their use more prevalent for treating extracranial pseudoaneurysms, fewer pseudoaneurysms are treated with medical therapy alone. This study aimed to assess the indications for intervention and the safety of medical management.</p><p><strong>Methods: </strong>A dual-center retrospective analysis was conducted on patients diagnosed with extracranial carotid and vertebral pseudoaneurysms between December 2006 and June 2023.</p><p><strong>Results: </strong>Of 145 pseudoaneurysms, 121 (83%) received medical therapy, 22 (15%) were treated endovascularly, and 2 (1.4%) were treated with open surgery. In the medical group, there were 2 (1.9%) complications, one unrelated to the pseudoaneurysm. In the intervention group, there were 3 (16%) complications, with 1 patient requiring two retreatments and sacrifice of the vessel. Major trauma (OR 4.0, 95% CI 1.3-14; p = 0.02), use of digital subtraction angiography as the initial imaging modality (OR 9.8, 95% CI 2.5-42; p < 0.01), and a maximum lesion diameter > 6 mm (OR 5.3, 95% CI 1.4-25; p = 0.03) proved to be significant in the decision to intervene. At a median follow-up of 18.1 months, 94.7% of the lesions treated with intervention healed completely compared with 19% of aneurysms in the medical group. Among those medically managed that did not resolve, the median change in diameter was -0.4 mm (IQR -1.8 to 0.4 mm). Age ≤ 50 years and aneurysm maximum diameter ≤ 6 mm predicted healing at follow-up in the medical group with 92% specificity and 65% sensitivity (area under the curve 0.87). At follow-up, 98% of patients were functionally independent (modified Rankin Scale score ≤ 2).</p><p><strong>Conclusions: </strong>Medical management alone is safe for most extracranial pseudoaneurysms, resulting in significantly fewer complications than endovascular intervention. Maximum diameter ≤ 6 mm and age ≤ 50 years were significant predictors of pseudoaneurysm resolution with medical therapy alone. Lesions that do not heal do not cause further symptoms or require additional intervention.</p>","PeriodicalId":16505,"journal":{"name":"Journal of neurosurgery","volume":" ","pages":"1-11"},"PeriodicalIF":3.5000,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of neurosurgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3171/2024.6.JNS24732","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: As endovascular interventions become safer and their use more prevalent for treating extracranial pseudoaneurysms, fewer pseudoaneurysms are treated with medical therapy alone. This study aimed to assess the indications for intervention and the safety of medical management.

Methods: A dual-center retrospective analysis was conducted on patients diagnosed with extracranial carotid and vertebral pseudoaneurysms between December 2006 and June 2023.

Results: Of 145 pseudoaneurysms, 121 (83%) received medical therapy, 22 (15%) were treated endovascularly, and 2 (1.4%) were treated with open surgery. In the medical group, there were 2 (1.9%) complications, one unrelated to the pseudoaneurysm. In the intervention group, there were 3 (16%) complications, with 1 patient requiring two retreatments and sacrifice of the vessel. Major trauma (OR 4.0, 95% CI 1.3-14; p = 0.02), use of digital subtraction angiography as the initial imaging modality (OR 9.8, 95% CI 2.5-42; p < 0.01), and a maximum lesion diameter > 6 mm (OR 5.3, 95% CI 1.4-25; p = 0.03) proved to be significant in the decision to intervene. At a median follow-up of 18.1 months, 94.7% of the lesions treated with intervention healed completely compared with 19% of aneurysms in the medical group. Among those medically managed that did not resolve, the median change in diameter was -0.4 mm (IQR -1.8 to 0.4 mm). Age ≤ 50 years and aneurysm maximum diameter ≤ 6 mm predicted healing at follow-up in the medical group with 92% specificity and 65% sensitivity (area under the curve 0.87). At follow-up, 98% of patients were functionally independent (modified Rankin Scale score ≤ 2).

Conclusions: Medical management alone is safe for most extracranial pseudoaneurysms, resulting in significantly fewer complications than endovascular intervention. Maximum diameter ≤ 6 mm and age ≤ 50 years were significant predictors of pseudoaneurysm resolution with medical therapy alone. Lesions that do not heal do not cause further symptoms or require additional intervention.

评估颅外假性动脉瘤药物治疗的安全性和有效性:一项比较研究。
目的:随着血管内介入治疗变得越来越安全,其在治疗颅外假性动脉瘤中的应用也越来越普遍,仅采用药物治疗的假性动脉瘤越来越少。本研究旨在评估介入治疗的适应症和药物治疗的安全性:方法:对2006年12月至2023年6月期间诊断为颅外颈动脉和椎体假性动脉瘤的患者进行双中心回顾性分析:在145例假动脉瘤患者中,121例(83%)接受了药物治疗,22例(15%)接受了血管内治疗,2例(1.4%)接受了开放手术治疗。药物治疗组有 2 例(1.9%)并发症,其中一例与假性动脉瘤无关。介入治疗组出现了 3 例(16%)并发症,其中 1 例患者需要进行两次复查并切除血管。重大创伤(OR 4.0,95% CI 1.3-14;p = 0.02)、使用数字减影血管造影作为初始成像方式(OR 9.8,95% CI 2.5-42;p < 0.01)和最大病变直径大于 6 毫米(OR 5.3,95% CI 1.4-25;p = 0.03)被证明对介入治疗的决定有重要影响。在中位随访18.1个月时,94.7%接受介入治疗的病变完全愈合,而医疗组只有19%的动脉瘤完全愈合。在未痊愈的药物治疗动脉瘤中,直径变化的中位数为-0.4毫米(IQR-1.8至0.4毫米)。年龄≤50岁和动脉瘤最大直径≤6毫米可预测医疗组随访时的愈合情况,特异性为92%,灵敏度为65%(曲线下面积为0.87)。随访时,98%的患者功能独立(改良Rankin量表评分≤2):结论:对大多数颅外假性动脉瘤而言,单纯药物治疗是安全的,并发症明显少于血管内介入治疗。最大直径≤6毫米和年龄≤50岁是单纯药物治疗假性动脉瘤的重要预测因素。未愈合的病变不会引起进一步的症状,也不需要额外的介入治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of neurosurgery
Journal of neurosurgery 医学-临床神经学
CiteScore
7.20
自引率
7.30%
发文量
1003
审稿时长
1 months
期刊介绍: The Journal of Neurosurgery, Journal of Neurosurgery: Spine, Journal of Neurosurgery: Pediatrics, and Neurosurgical Focus are devoted to the publication of original works relating primarily to neurosurgery, including studies in clinical neurophysiology, organic neurology, ophthalmology, radiology, pathology, and molecular biology. The Editors and Editorial Boards encourage submission of clinical and laboratory studies. Other manuscripts accepted for review include technical notes on instruments or equipment that are innovative or useful to clinicians and researchers in the field of neuroscience; papers describing unusual cases; manuscripts on historical persons or events related to neurosurgery; and in Neurosurgical Focus, occasional reviews. Letters to the Editor commenting on articles recently published in the Journal of Neurosurgery, Journal of Neurosurgery: Spine, and Journal of Neurosurgery: Pediatrics are welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信